120 related articles for article (PubMed ID: 16179921)
1. Trapped in action: direct visualization of DNA methyltransferase activity in living cells.
Schermelleh L; Spada F; Easwaran HP; Zolghadr K; Margot JB; Cardoso MC; Leonhardt H
Nat Methods; 2005 Oct; 2(10):751-6. PubMed ID: 16179921
[TBL] [Abstract][Full Text] [Related]
2. Visualization and measurement of DNA methyltransferase activity in living cells.
Schermelleh L; Spada F; Leonhardt H
Curr Protoc Cell Biol; 2008 Jun; Chapter 22():Unit 22.12. PubMed ID: 18551419
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of DNA methyltransferase activity prevents tumorigenesis in a mouse model of prostate cancer.
McCabe MT; Low JA; Daignault S; Imperiale MJ; Wojno KJ; Day ML
Cancer Res; 2006 Jan; 66(1):385-92. PubMed ID: 16397253
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of Dnmt1 interaction with the replication machinery and its role in postreplicative maintenance of DNA methylation.
Schermelleh L; Haemmer A; Spada F; Rösing N; Meilinger D; Rothbauer U; Cardoso MC; Leonhardt H
Nucleic Acids Res; 2007; 35(13):4301-12. PubMed ID: 17576694
[TBL] [Abstract][Full Text] [Related]
5. DNMT1 but not its interaction with the replication machinery is required for maintenance of DNA methylation in human cells.
Spada F; Haemmer A; Kuch D; Rothbauer U; Schermelleh L; Kremmer E; Carell T; Längst G; Leonhardt H
J Cell Biol; 2007 Feb; 176(5):565-71. PubMed ID: 17312023
[TBL] [Abstract][Full Text] [Related]
6. In living color: DNA methyltransferase caught in the act.
Schuebel K; Baylin S
Nat Methods; 2005 Oct; 2(10):736-8. PubMed ID: 16179918
[No Abstract] [Full Text] [Related]
7. De novo DNA methyltransferases Dnmt3a and Dnmt3b primarily mediate the cytotoxic effect of 5-aza-2'-deoxycytidine.
Oka M; Meacham AM; Hamazaki T; Rodić N; Chang LJ; Terada N
Oncogene; 2005 Apr; 24(19):3091-9. PubMed ID: 15735669
[TBL] [Abstract][Full Text] [Related]
8. Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation.
Reu FJ; Bae SI; Cherkassky L; Leaman DW; Lindner D; Beaulieu N; MacLeod AR; Borden EC
J Clin Oncol; 2006 Aug; 24(23):3771-9. PubMed ID: 16801630
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic modifications affect Dnmt3L expression.
Aapola U; Mäenpää K; Kaipia A; Peterson P
Biochem J; 2004 Jun; 380(Pt 3):705-13. PubMed ID: 15015937
[TBL] [Abstract][Full Text] [Related]
10. Restricted mobility of Dnmt1 in preimplantation embryos: implications for epigenetic reprogramming.
Grohmann M; Spada F; Schermelleh L; Alenina N; Bader M; Cardoso MC; Leonhardt H
BMC Dev Biol; 2005 Aug; 5():18. PubMed ID: 16120212
[TBL] [Abstract][Full Text] [Related]
11. Role of the DNA methyltransferase variant DNMT3b3 in DNA methylation.
Weisenberger DJ; Velicescu M; Cheng JC; Gonzales FA; Liang G; Jones PA
Mol Cancer Res; 2004 Jan; 2(1):62-72. PubMed ID: 14757847
[TBL] [Abstract][Full Text] [Related]
12. Major and essential role for the DNA methylation mark in mouse embryogenesis and stable association of DNMT1 with newly replicated regions.
Takebayashi S; Tamura T; Matsuoka C; Okano M
Mol Cell Biol; 2007 Dec; 27(23):8243-58. PubMed ID: 17893328
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells.
Cheng JC; Auersperg N; Leung PC
Oncogene; 2011 Sep; 30(37):3930-42. PubMed ID: 21478913
[TBL] [Abstract][Full Text] [Related]
14. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
[TBL] [Abstract][Full Text] [Related]
15. The activity of the murine DNA methyltransferase Dnmt1 is controlled by interaction of the catalytic domain with the N-terminal part of the enzyme leading to an allosteric activation of the enzyme after binding to methylated DNA.
Fatemi M; Hermann A; Pradhan S; Jeltsch A
J Mol Biol; 2001 Jun; 309(5):1189-99. PubMed ID: 11399088
[TBL] [Abstract][Full Text] [Related]
16. Effects of DNA methyltransferase inhibitors (DNMTIs) on MDS-derived cell lines.
Tsujioka T; Yokoi A; Uesugi M; Kishimoto M; Tochigi A; Suemori S; Tohyama Y; Tohyama K
Exp Hematol; 2013 Feb; 41(2):189-97. PubMed ID: 23085465
[TBL] [Abstract][Full Text] [Related]
17. Identification of a genomic fragment that directs hematopoietic-specific expression of Rac2 and analysis of the DNA methylation profile of the gene locus.
Ladd PD; Butler JS; Skalnik DG
Gene; 2004 Oct; 341():323-33. PubMed ID: 15474314
[TBL] [Abstract][Full Text] [Related]
18. DNA (cytosine-5)-methyltransferases in mouse cells and tissues. Studies with a mechanism-based probe.
Yoder JA; Soman NS; Verdine GL; Bestor TH
J Mol Biol; 1997 Jul; 270(3):385-95. PubMed ID: 9237905
[TBL] [Abstract][Full Text] [Related]
19. IL-6 enhances the nuclear translocation of DNA cytosine-5-methyltransferase 1 (DNMT1) via phosphorylation of the nuclear localization sequence by the AKT kinase.
Hodge DR; Cho E; Copeland TD; Guszczynski T; Yang E; Seth AK; Farrar WL
Cancer Genomics Proteomics; 2007; 4(6):387-98. PubMed ID: 18204201
[TBL] [Abstract][Full Text] [Related]
20. Long term instability and molecular mechanism of 5-azacytidine-induced DNA hypomethylation in normal and neoplastic tissues in vivo.
Lu LJ; Randerath K
Mol Pharmacol; 1984 Nov; 26(3):594-603. PubMed ID: 6208475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
